| Schedule of Segment Reporting |
Segment revenue, net loss and reconciliations from segment revenue to segment net loss were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Revenue | | | | | | | | | Commercial operations | $ | 15,420 | | | $ | — | | | $ | 26,085 | | | $ | — | | | Research and Development operations | 183 | | | — | | | 424 | | | — | | | Total revenue | $ | 15,603 | | | $ | — | | | $ | 26,509 | | | $ | — | | | | | | | | | | | Net loss | | | | | | | | | Commercial operations | $ | (23,000) | | | $ | — | | | $ | (48,128) | | | $ | — | | | Research and Development operations | (417) | | | (3,449) | | | (362) | | | (5,417) | | | Net loss | $ | (23,417) | | | $ | (3,449) | | | $ | (48,490) | | | $ | (5,417) | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | For the Three Months Ended
June 30, 2026 | | For the Three Months Ended
June 30, 2025 | | Commercial Operations | | Research and Development Operations | | Total | | Commercial Operations | | Research and Development Operations | | Total | | | | | | | | | | | | | | Revenue | $ | 15,420 | | | $ | 183 | | | $ | 15,603 | | | $ | — | | | $ | — | | | $ | — | | | Less: | | | | | | | | | | | | | Cost of goods sold | (3,610) | | | — | | | (3,610) | | | — | | | — | | | — | | | Selling, general and administrative | (27,673) | | | — | | | (27,673) | | | — | | | (2,716) | | | (2,716) | | | Research and development | — | | | (600) | | | (600) | | | — | | | (515) | | | (515) | | | Amortization of intangible assets | (1,043) | | | — | | | (1,043) | | | — | | | — | | | — | | | Interest expense | (2,389) | | | — | | | (2,389) | | | — | | | (218) | | | (218) | | | Change in fair value of convertible debt | (3,705) | | | — | | | (3,705) | | | — | | | — | | | — | | | Net loss | $ | (23,000) | | | $ | (417) | | | $ | (23,417) | | | $ | — | | | $ | (3,449) | | | $ | (3,449) | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | For the Six Months Ended
June 30, 2026 | | For the Six Months Ended
June 30, 2025 | | Commercial Operations | | Research and Development Operations | | Total | | Commercial Operations | | Research and Development Operations | | Total | | | | | | | | | | | | | | Revenue | $ | 26,085 | | | $ | 424 | | | $ | 26,509 | | | $ | — | | | $ | — | | | $ | — | | | Less: | | | | | | | | | | | | | Cost of goods sold | (5,283) | | | — | | | (5,283) | | | — | | | — | | | — | | | Selling, general and administrative | (48,777) | | | — | | | (48,777) | | | — | | | (4,356) | | | (4,356) | | | Research and development | — | | | (786) | | | (786) | | | — | | | (709) | | | (709) | | | Amortization of intangible assets | (2,074) | | | — | | | (2,074) | | | — | | | — | | | — | | | Interest expense | (4,742) | | | — | | | (4,742) | | | — | | | (352) | | | (352) | | | Change in fair value of convertible debt | (13,337) | | | — | | | (13,337) | | | — | | | — | | | — | | | Net loss | $ | (48,128) | | | $ | (362) | | | $ | (48,490) | | | $ | — | | | $ | (5,417) | | | $ | (5,417) | |
Additional significant non-cash expenses are presented below. | | | | | | | | | | | | | | | | | | | | | | | | | For the Three Months Ended June 30, | For the Six Months Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | | | | | | | | | Depreciation | $ | 278 | | | $ | — | | | $ | 747 | | | $ | — | | | Stock-based compensation | 2,760 | | | 394 | | | 4,668 | | | 850 | |
Segment total assets were as follows: | | | | | | | | | | | | | As of June 30, 2026 | | As of December 31, 2025 | | Assets | | | | | Commercial operations | $ | 136,950 | | | $ | 129,292 | | | Research and Development operations | 406 | | | 1,105 | | | Total assets | $ | 137,356 | | | $ | 130,397 | |
|